Results 291 to 300 of about 436,688 (335)
Some of the next articles are maybe not open access.
Adenocarcinoma of the lung: Clinicopathological study
Journal of Surgical Oncology, 1975AbstractA review of our 247 patients with adenocarcinoma of the lung revealed the overall five year survival rate to be only 0.81%.Lung resection offers the chance of cure if the lesion is peripherally located and without lymph node involvement. Direct chest wall invasion by tumor is not contraindication to surgery. Radiation therapy was not especially
P, Marabella, H, Takita
openaire +2 more sources
Raised Pleural Fluid Amylase Level as an Aid in the Diagnosis of Adenocarcinoma of the Lung
The British journal of clinical practice, 1984SUMMARY The pleural fluid amylase level was measured in 110 patients who were consecutively admitted to hospital with a pleural effusion. A primary lung tumour was diagnosed in 46 (42 per cent) of the cases, and a primary adenocarcinoma of the lung was ...
H. Buckler, D. Honeybourne
semanticscholar +1 more source
Rare subtypes of adenocarcinoma of the lung
Expert Review of Anticancer Therapy, 2011The 1999 WHO classification of adenocarcinoma of the lung and pleural tumors listed five rare variants of adenocarcinoma of the lung: well-differentiated fetal adenocarcinoma, colloid 'mucinous' adenocarcinoma, mucinous cystadenocarcinoma, signet ring adenocarcinoma and clear-cell adenocarcinoma.
Ou, S.-H.I. +3 more
openaire +2 more sources
Minimally Invasive Adenocarcinomas of the Lung
Advances in Anatomic Pathology, 2009Current World Health Organization (WHO) classification of lung adenocarcinomas includes noninvasive bronchioloalveolar carcinoma (BAC) and several patterns of invasive adenocarcinoma. The most common is a mixed subtype of adenocarcinoma. This group is very heterogenous and includes a wide spectrum of tumors ranging from adenocarcinomas with a dominant ...
openaire +2 more sources
Journal of the American Chemical Society, 2019
Therapeutic target identification and corresponding drug development is a demanding task for the treatment of lung adeno-carcinoma, especially the most malignant proximal-proliferative subtype without druggable protein kinase mutations.
W. Zhou +9 more
semanticscholar +1 more source
Therapeutic target identification and corresponding drug development is a demanding task for the treatment of lung adeno-carcinoma, especially the most malignant proximal-proliferative subtype without druggable protein kinase mutations.
W. Zhou +9 more
semanticscholar +1 more source
Changing Rates of Adenocarcinoma of the Lung
Chemical Research in Toxicology, 2014Over the past several decades, adenocarcinoma of the lung has been increasing as a fraction of all lung cancer. Examination of the available evidence led the 2014 Report of the Surgeon General to conclude that the increases in the rates of adenocarcinoma among smokers in the U.S.
openaire +2 more sources
Combined Choriocarcinoma and Adenocarcinoma of the Lung
Acta Pathologica Japonica, 1989Combined choriocarcinoma and adenocarcinoma in the lung of a 71‐year‐old Japanese male is reported. In the upper lobe of the right lung (S1+ 2), a choriocarcinoma coexisted with an adenocarcinoma, but distinct metastatic lesions were noticed separately in the lungs, kidney, bone marrow and lymph nodes.
H, Adachi +4 more
openaire +2 more sources
Adenocarcinoma of the lung with metatarsal metastasis
The Journal of Foot and Ankle Surgery, 1996Foot pain is a most unusual presentation of metastatic malignancy. Metastases to the hands or feet (acrometastases) have been recognized in only a few cases. A 68-year-old male, with a history of chronic gout, presented with left foot pain for 3 months duration.
M J, Kemnitz +4 more
openaire +2 more sources
Hepatoid adenocarcinoma of the lung
Diagnostic Cytopathology, 2019Kevin Kuan +2 more
openaire +2 more sources
Cystic Adenocarcinoma of the Lung
Archivos de Bronconeumología (English Edition), 2019Israel, Rodríguez Alvarado +2 more
openaire +2 more sources